Enzolytics (Enzolytics) Deferred Tax : $0.00 Mil (TTM As of Jun. 2011)

View and export this data going back to 2008. Start your Free Trial

What is Enzolytics Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Enzolytics's change in deferred tax for the three months ended in Jun. 2011 was $0.00 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Jun. 2011 was $0.00 Mil.

Enzolytics Deferred Tax Historical Data

The historical data trend for Enzolytics's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enzolytics Deferred Tax Chart

Enzolytics Annual Data

Trend

Dec07

Jul08

Dec09

Dec10

Deferred Tax

Enzolytics Quarterly Data
	Sep07	Dec07	Apr08	Jul08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11
Deferred Tax	Get a 7-Day Free Trial										-	-	-	-	-

Enzolytics Deferred Tax Calculation

Deferred Tax for the trailing twelve months (TTM) ended in Jun. 2011 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Enzolytics Deferred Tax Related Terms

Thank you for viewing the detailed overview of Enzolytics's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

Enzolytics (Enzolytics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Enzolytics Inc (OTCPK:ENZC) » Definitions » Deferred Tax

Traded in Other Exchanges

N/A

Address

1101 Raintree Circle, Suite 130, Allen, TX, USA, 75013

Website

https://www.enzolytics.com

Enzolytics Inc is a biotechnology company, whose products consist of multiple distinct drug development proprietary technologies: Immunotherapy, immune modulators, fully human monoclonal antibodies, and an artificial intelligence (AI) platform for health care developments. It has clinically tested anti-HIV therapeutics. Additionally, the Company has created a proprietary cell line that produces fully human monoclonal antibodies that target and neutralizes the HIV virus.